Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Jon Bardsley of Thermo Fisher offers his perspective regarding the advancement of PFAS detection in pharmaceutical manufacturing with liquid chromatography-mass spectrometry (LC-MS), and the influence ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...

In the complex world of pharmaceutical development, clinical trials represent both a critical opportunity and a significant challenge. The site selection process, crucial for trial success, has ...

In the late 2010s, Novo Nordisk shelved a weekly obesity treatment that targeted three hormones at once, though it caused notable weight loss in mice ...

The pharmaceutical industry is a high-pressure world, where companies scramble to outpace rivals, slash trial failures, and bring drugs to market faster. With costs skyrocketing and breakthroughs hard ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The health outcomes speak for themselves: France ranks third globally in child well-being, while the U.S. ranks 36 th. The ...

The Bangladesh Association of Pharmaceuticals Industries (BAPI) views the proposed extension and enhancement of duty and tax exemptions on the import of raw materials for the pharmaceutical sector in ...

The Chronicle spoke with Duke alumnus and professor Robert Califf about the recent “Make America Healthy Again” report and ...

The pharmaceutical industry is rapidly growing right here in the east, and events like today’s Spring Pharma Conference at ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...